Shi Hu Selected Research

S100 calcium binding protein A10

7/2021

MALDI-MS-based biomarker analysis of extracellular vesicles from human lung carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shi Hu Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 11/2013
4	Breast Neoplasms (Breast Cancer) 01/2018 - 12/2012
3	Stomach Neoplasms (Stomach Cancer) 09/2017 - 03/2014
2	Cytokine Release Syndrome 01/2022 - 01/2019
2	Heart Diseases (Heart Disease) 11/2021 - 01/2021
2	Disease Progression 07/2021 - 01/2016
2	COVID-19 01/2021 - 01/2020
2	Proteinuria 01/2019 - 01/2016
2	Carcinogenesis 02/2017 - 01/2015
2	Colorectal Neoplasms (Colorectal Cancer) 11/2016 - 11/2014
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Hypertension (High Blood Pressure) 11/2021
1	Carcinoma (Carcinomatosis) 07/2021
1	Lung Neoplasms (Lung Cancer) 07/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Shock 12/2020
1	Flail Chest 11/2020
1	Respiratory Insufficiency (Respiratory Failure) 11/2020
1	Rib Fractures (Rib Fracture) 11/2020
1	Wounds and Injuries (Trauma) 11/2020
1	Poisoning 02/2020
1	Sepsis (Septicemia) 10/2019
1	Neuroblastoma 05/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Heart Failure 12/2018
1	Infarction (Infarctions) 12/2018
1	Hepatitis 01/2018
1	Inflammation (Inflammations) 01/2018
1	Pathologic Processes 01/2018
1	Platelet Glycoprotein IV Deficiency 01/2018
1	Atherosclerosis 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2016
1	Esophageal Neoplasms (Esophageal Cancer) 11/2014
1	Neoplasm Metastasis (Metastasis) 11/2014

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 07/2021 - 01/2016
5	Trastuzumab (Herceptin)FDA Link 01/2017 - 12/2012
4	AntibodiesIBA 07/2019 - 01/2015
4	ErbB Receptors (EGF Receptor)IBA 01/2017 - 01/2015
4	Cetuximab (Erbitux)FDA Link 11/2016 - 12/2012
3	Pharmaceutical PreparationsIBA 01/2021 - 03/2014
2	AntigensIBA 01/2022 - 01/2022
2	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2019
2	Urea (Carbamide)FDA LinkGeneric 11/2021 - 01/2021
2	Biological ProductsIBA 01/2021 - 11/2014
2	HydrogenIBA 12/2020 - 02/2020
2	AlkaloidsIBA 10/2019 - 05/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2019 - 01/2015
2	Immunoglobulin G (IgG)IBA 01/2019 - 01/2016
2	Bispecific AntibodiesIBA 01/2019 - 01/2015
2	LigandsIBA 01/2018 - 01/2017
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017 - 11/2016
2	pertuzumabIBA 01/2015 - 11/2013
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Antigen Receptors (Antigen Receptor)IBA 01/2022
1	CreatinineIBA 11/2021
1	S100 calcium binding protein A10IBA 07/2021
1	Biomarkers (Surrogate Marker)IBA 07/2021
1	Ribosomal Proteins (Ribosomal Protein)IBA 07/2021
1	Therapeutic UsesIBA 01/2021
1	AlbuminsIBA 01/2021
1	NitrogenIBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	AlloysIBA 12/2020
1	Carbon Nanotubes (Carbon Nanotube)IBA 12/2020
1	Angiotensin-Converting Enzyme 2IBA 01/2020
1	carbazoleIBA 10/2019
1	MelatoninIBA 10/2019
1	Neuroprotective AgentsIBA 05/2019
1	Oxidopamine (6 Hydroxydopamine)IBA 05/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2019
1	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 01/2019
1	tarextumabIBA 01/2019
1	AutoantibodiesIBA 01/2019
1	Antinuclear AntibodiesIBA 01/2019
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 12/2018
1	Presenilin-1IBA 12/2018
1	InterleukinsIBA 01/2018
1	EnzymesIBA 01/2018
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2018
1	Concanavalin AIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2018
1	CXC ChemokinesIBA 01/2018
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2018
1	Chemokine CXCL10IBA 01/2018
1	withanolide DIBA 01/2018
1	Phosphotransferases (Kinase)IBA 09/2017
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 02/2017
1	Succinic Acid (Succinate)IBA 02/2017
1	Monoclonal AntibodiesIBA 11/2016
1	Histones (Histone)IBA 01/2016
1	CateninsIBA 11/2014
1	saracatinibIBA 03/2014

Therapy/Procedure

11	Therapeutics 01/2022 - 09/2013
1	Immunotherapy 01/2022
1	Length of Stay 11/2020
1	Cannula 11/2020
1	Treatment Delay 01/2016